Michael Oumano, Richard Wendt, James Botti, Nathan Busse, David Hintenlang, Stephanie Leon, Kevin Little, Melissa Martin, Richard Massoth, Kenneth Matthews, Rameshwar Prasad, Sharon White, Jessica Clements
{"title":"Shielding resources for four common radiopharmaceuticals utilized for imaging and therapy: Tc-99m, F-18, I-131, and Lu-177.","authors":"Michael Oumano, Richard Wendt, James Botti, Nathan Busse, David Hintenlang, Stephanie Leon, Kevin Little, Melissa Martin, Richard Massoth, Kenneth Matthews, Rameshwar Prasad, Sharon White, Jessica Clements","doi":"10.1002/acm2.70084","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The use of radioactive materials in the United States has been tightly regulated by the Nuclear Regulatory Commission and other entities for many decades. In 2015, however, the Joint Commission began to require hospital-based nuclear medicine departments to conduct shielding designs and evaluations for radioactive material areas, mirroring established x-ray practices. NCRP Report No. 147 guides diagnostic medical x-ray shielding, but obviously cannot be used alone for nuclear medicine applications. The rising demand for theranostic nuclear medicine shielding evaluations particularly necessitates updated focused guidance, the aim of this report.</p><p><strong>Methods: </strong>Monte Carlo simulations were conducted using GATE software to analyze the effects of various barriers on the transmission of radioactive emissions. The simulations used point sources of Tc-99m, F-18, I-131, and Lu-177 and evaluated dose deposition to blocks of tissue using Dose Actors. Different ceiling heights (ranging from 10-16 feet) were also tested for scattering effects. The Archer equation was employed to fit transmission curves and estimate required barrier thicknesses.</p><p><strong>Results: </strong>Broad beam transmission factors and Archer fitting parameters are reported for various materials including lead, gypsum, concrete (light weight and normal weight), glass, and steel. A sample shielding calculation is provided for a wall separating Lu-177 dotatate patients from an adjacent office to maintain public dose limits. Relevant occupancy factors are also provided.</p><p><strong>Conclusions: </strong>While Lu-177 has a relatively low exposure rate constant, shielding may be necessary for high-volume therapies like Lu-177 DOTATATE and Lu-177 vipivotide tetraxetan PSMA. Shielding involves accounting for broad radiation beams and requires thorough characterization of radiation buildup. When shielding to the typical height of 7 feet, scatter from ceilings and floors is negligible for transmission above 10%, but severely limits the ability to shield for transmission below 1%.</p>","PeriodicalId":14989,"journal":{"name":"Journal of Applied Clinical Medical Physics","volume":" ","pages":"e70084"},"PeriodicalIF":2.0000,"publicationDate":"2025-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Applied Clinical Medical Physics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/acm2.70084","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: The use of radioactive materials in the United States has been tightly regulated by the Nuclear Regulatory Commission and other entities for many decades. In 2015, however, the Joint Commission began to require hospital-based nuclear medicine departments to conduct shielding designs and evaluations for radioactive material areas, mirroring established x-ray practices. NCRP Report No. 147 guides diagnostic medical x-ray shielding, but obviously cannot be used alone for nuclear medicine applications. The rising demand for theranostic nuclear medicine shielding evaluations particularly necessitates updated focused guidance, the aim of this report.
Methods: Monte Carlo simulations were conducted using GATE software to analyze the effects of various barriers on the transmission of radioactive emissions. The simulations used point sources of Tc-99m, F-18, I-131, and Lu-177 and evaluated dose deposition to blocks of tissue using Dose Actors. Different ceiling heights (ranging from 10-16 feet) were also tested for scattering effects. The Archer equation was employed to fit transmission curves and estimate required barrier thicknesses.
Results: Broad beam transmission factors and Archer fitting parameters are reported for various materials including lead, gypsum, concrete (light weight and normal weight), glass, and steel. A sample shielding calculation is provided for a wall separating Lu-177 dotatate patients from an adjacent office to maintain public dose limits. Relevant occupancy factors are also provided.
Conclusions: While Lu-177 has a relatively low exposure rate constant, shielding may be necessary for high-volume therapies like Lu-177 DOTATATE and Lu-177 vipivotide tetraxetan PSMA. Shielding involves accounting for broad radiation beams and requires thorough characterization of radiation buildup. When shielding to the typical height of 7 feet, scatter from ceilings and floors is negligible for transmission above 10%, but severely limits the ability to shield for transmission below 1%.
期刊介绍:
Journal of Applied Clinical Medical Physics is an international Open Access publication dedicated to clinical medical physics. JACMP welcomes original contributions dealing with all aspects of medical physics from scientists working in the clinical medical physics around the world. JACMP accepts only online submission.
JACMP will publish:
-Original Contributions: Peer-reviewed, investigations that represent new and significant contributions to the field. Recommended word count: up to 7500.
-Review Articles: Reviews of major areas or sub-areas in the field of clinical medical physics. These articles may be of any length and are peer reviewed.
-Technical Notes: These should be no longer than 3000 words, including key references.
-Letters to the Editor: Comments on papers published in JACMP or on any other matters of interest to clinical medical physics. These should not be more than 1250 (including the literature) and their publication is only based on the decision of the editor, who occasionally asks experts on the merit of the contents.
-Book Reviews: The editorial office solicits Book Reviews.
-Announcements of Forthcoming Meetings: The Editor may provide notice of forthcoming meetings, course offerings, and other events relevant to clinical medical physics.
-Parallel Opposed Editorial: We welcome topics relevant to clinical practice and medical physics profession. The contents can be controversial debate or opposed aspects of an issue. One author argues for the position and the other against. Each side of the debate contains an opening statement up to 800 words, followed by a rebuttal up to 500 words. Readers interested in participating in this series should contact the moderator with a proposed title and a short description of the topic